News
TDDA continues to lead the way with drug testing innovation as featured in the DEMM Engineering & Manufacturing publication – “TDDA adds Tramadol and Fentanyl testing”
https://demm.co.nz/article/tdda-adds-tramadol-and-fentanyl-testingRead more
Imperans Q4 Report, State of Workplace Drug Use from TDDA
Recent data indicates an increase in amphetamine-type substances and opioids AUCKLAND, New Zealand, 25 February 2024 – The Drug Detection Agency...
COMING SOON – 2 new drug types added to TDDA drug screening devices
TDDA are proud to announce the soon to be released updated TDDA branded oral fluid and urine screening devices that includes the option of 2 extra...
An alert has been put out in New Zealand for a new synthetic cannabinoid being misrepresented as a benzodiazepine. This highlights the dangers of synthetic drugs being marketed as another type of drug creating the high potential of harm to users.
https://www.highalert.org.nz/alerts-and-notifications/new-synthetic-cannabinoid-misrepresented-as-a-benzodiazepinehttps://www.highalert.org.nz/alerts-and-notifications/new-synthetic-cannabinoid-misrepresented-as-a-benzodiazepine
Opinion Piece: Time to Reevaluate the Medicinal Cannabis Framework
By Glenn Dobson, CEO of The Drug Detection Agency (TDDA) The rapid expansion of the medicinal cannabis market in Australia and New Zealand raises...
Opinion: Leadership Must Prioritise Managing Workplace Safety Risks
By Glenn Dobson, CEO of The Drug Detection Agency The recent media reports relating to the New Zealand court ruling following the tragic death of a...
TDDA sponsor the Australian HR Institute (AHRI) in Hobart, Tasmania
Last week, TDDA proudly served as one of the seven sponsors at the Australian HR Institute (AHRI) state conference, held at the Crowne Plaza in...
‘Living document’: Employers urged to keep drug-testing policies updated amid shifting trends
In this insightful article, Glenn Dobson discusses the critical need for employers to regularly update their drug and alcohol policies to ensure...
TDDA Launches Imperans Report, a New Quarterly Workplace Drug Use Snapshot
Imperans Report to Provide Businesses with Actionable Health and Safety Information AUCKLAND, New Zealand, 04 November 2024 – The Drug Detection...
AUSTRLALIA & NEW ZEALAND’S MEDICINAL CANNABIS MARKET – LEGITIMATE MEDICINE OR LEGALISATION UNDER ANOTHER NAME?
October 2024 As the CEO of TDDA, it is critical to highlight the increasing safety risks surrounding the shift from CBD-dominant medicinal cannabis...